HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative; Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”)), has recently issued new shares through a third-party allotment to EASTERN CAR LINER, LTD. (headquartered in Shinagawa-ku, Tokyo; Shigeru Nagate, CEO).
Since its commercialization in January 2020, the nematode cancer test “N-NOSE” has expanded its services, and the number of examinees has exceeded 600,000. We will continue to focus on research and development with the aim of contributing to a world where cancer can be detected early. Alongside Eastern Car Liner Ltd., we will work towards expanding the business of N-NOSE and enhancing its services to ensure it can be utilized by even more people.
<About EASTERN CAR LINER, LTD.>
Company Name: EASTERN CAR LINER, LTD.
Headquarters: Tennozu Parkside Building, 2-5-8 Higashi-Shinagawa, Shinagawa-ku, Tokyo
Representative: Shigeru Nagate, CEO
Date of Establishment: May 11, 1977
Main Business: Marine transportation (Liner service, Tramper service and Chartering business) and transportation of automobiles, heavy vehicles, construction machinery, etc, to Southeast Asian countries, China, North America and Middle East countries on pure car carriers and multipurpose vessels.
Official Website: https://www.ecl.co.jp/en/
HIROTSU BIO SCIENCE INC. (Head Office: Tokyo; Representative Director, President, and CEO; Takaaki Hirotsu (Hereinafter referred to as “HIROTSU” . . .
2025.03.06The international biomedical journal Biomedicines has just published a peer-reviewed review article* on data showing the effectiveness of N-NOSE . . .
2024.11.15At the Excellence in Oncology Care (EIOC) 2024 conference held in Dubai from October 11 (Fri.) to 13 (Sun.), 2024, our Shonan R&D Center Res . . .
2024.10.25